WAT · Waters Corporation

S&P 500 #278 · NYSE

Risiko 4/10 · Biopharma instruments, high-quality compounder · $383.90 ▲ 3.42%

Kennzahlen

• Price $383.90
• Market cap $37.7B
• P/E (ttm) 48.78
• Div yield none
• 52-wk range $275.05 – $414.15
• Index rank #278 / —

Wichtigste Risiken

• Stretched trailing P/E (~47x) (Valuation headroom) — MED
• Biopharma capex budget cuts (Instrument sales) — MED
• Strong USD hurting international revenue (Reported EPS) — LOW
• Competitive pressure from Agilent/Thermo (Market share) — LOW

Fazit

Analytical-instruments leader in liquid chromatography/mass spec serving biopharma and multiomics; pristine business model but premium valuation requires continued mid-single-digit organic growth.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.